Category: Life Sciences
Life Sciences market research reports by Roots Analysis
-
Gene Switch Market - Distribution by Application Area (Management of Treatment Related Toxicity, Regulation of Gene Expression and Other Applications), Type of Target Therapy (CAR-T Cell Therapies, Gene Therapies and Other Therapies), Type of Payment Model Employed (Upfront Payments and Milestone Payments) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
Gene Switch Market - Distribution by Application Area (Management of Treatment Related Toxicity, Regulation of Gene Expression and Other Applications), Type of Target Therapy (CAR-T Cell Therapies, Gene Therapies and Other Therapies), Type of Payment Model Employed (Upfront Payments and Milestone Pa ... Read More
-
Pharmaceutical Polymers / Medical Polymers Market - Distribution by Type of Polymer (Thermoplastic Polymers, Elastomers, Thermoset Polymers and Others), Area of Application and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035
Pharmaceutical Polymers / Medical Polymers Market - Distribution by Type of Polymer (Thermoplastic Polymers, Elastomers, Thermoset Polymers and Others), Area of Application and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 INTRODUCTION Polymers represent a versatile class ... Read More
-
Filtration Market (Focus on Biologics Manufacturing), 2023-2035
Filtration Market (Focus on Biologics Manufacturing), 2023-2035 INTRODUCTION Biologics represents one of the fastest growing segments of the healthcare sector. In last five years, over 50 biologics been approved by the Food and Drug Administration (FDA) and close to 10,000 biologics are being evalua ... Read More
-
Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape
Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape INTRODUCTION Low drug solubility and its corresponding impact on bioavailability have remained a primary cause of concern with several marketed as well as clinical stage drugs. According to the Journal of Analytical and Pharmaceut ... Read More
-
Investor Series: Opportunities in RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers)
Investor Series: Opportunities in RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers) INTRODUCTION to RNA Therapeutics RNA therapeutics are known to target specific genetic sequences of individual patients, in order to provide more effective treatment option ... Read More
-
Genotoxicity / Mutagenicity Testing Services Market, 2023-2035
Genotoxicity / Mutagenicity Testing Services Market, 2023-2035 INTRODUCTION Genotoxicity refers to the property of hazardous (physical, chemical and biological) agents to cause damage to genetic information present within a cell. It is worth mentioning that this damage can lead to formation of mutat ... Read More
-
3D Bioprinting: Intellectual Property Landscape
3D Bioprinting: Intellectual Property Landscape Tissue injury and dysfunctioning commonly occurs in humans; however, not in all cases, the tissue regeneration capability of a human body is able to cope up with the damage caused. The conventional approach used to deal with this type of trauma involve ... Read More
-
Investor Series: Opportunities in Women’s Digital Health Market
Investor Series: Opportunities in Women’s Digital Health Market INTRODUCTION Digital health is a broad concept that encompasses telemedicine, teleconsultation, remote monitoring, connected devices, digital health platforms and health applications. The outbreak of COVID-19 pandemic has propelled the ... Read More
-
Viral Clearance and Testing Services Market, 2023-2035
Viral Clearance and Testing Services Market, 2023-2035 INTRODUCTION Viral clearance and testing refers to the detection and elimination of viral contaminants, using a wide array of methods, to ensure the product’s safety for human use. Over the past few years, viral clearance and testing has emerged ... Read More
-
Investor Series: Opportunities in Digital Therapeutics Market
Investor Series: Opportunities in Digital Therapeutics Market Digital therapeutics are clinically validated solutions that are delivered as applications, software and online programs, demonstrating the capability to facilitate positive outcomes when employed in the management of clinical conditions. ... Read More
-
Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Intracellular Biologics (2nd Edition), 2023-2035
Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Intracellular Biologics (2nd Edition), 2023-2035 In recent years, efficient methods for facilitation of intracellular drug delivery have become a prominent need within the modern biopharmaceutical industry. Targeting th ... Read More
-
Monkeypox Market: Focus on Therapeutics, Vaccines and Diagnostic Kits
Monkeypox Market: Focus on Therapeutics, Vaccines and Diagnostic Kits Monkeypox is a viral disease, which is usually transmitted to humans from animals. The disease is known to have symptoms similar to those observed in smallpox patients, although it is considered to be clinically less severe. Monke ... Read More
-
Investor Series: Opportunities in the AI-based Drug Discovery
Investor Series: Opportunities in the AI-based Drug Discovery The discovery and identification of novel drug candidates is a time-intensive process, which is fraught with several challenges. One of the main concerns associated with the drug development process is the high attrition rate, which is of ... Read More
-
Molecular Switches: Intellectual Property Landscape
Molecular Switches: Intellectual Property Landscape Attempts to synthetically recreate the biological circuits in human body is a relatively new area of research within synthetic biology. Ever since the 2010s, the use of molecular “toggle” switches to mimic electronic circuits has been prevalent to ... Read More
-
SARM1 Targeting Therapeutics Market, 2022-2040
SARM1 Targeting Therapeutics Market, 2022-2040 Neurological disorders are considered the second leading cause of death and the primary cause of long-term disability, worldwide. Across the globe, over 6.5 million neurological disorder related deaths are reported annually. Further, according to a re ... Read More
-
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035 Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. As these trials are prone to delays, and can even fail altogethe ... Read More
-
Bacteriophage Therapeutics Market, 2022-2035
Bacteriophage Therapeutics Market, 2022-2035 Antimicrobial resistance (AMR) has been identified as one of the greatest threats to public health. According to the Centers of Disease Control and Prevention, more than 2.8 million cases of AMR infections are identified in the United States on an annual ... Read More
-
Microbiome Therapeutics and Diagnostics: Intellectual Property Landscape
Microbiome Therapeutics and Diagnostics: Intellectual Property Landscape More than 10,000 unique species of microorganisms make up the human microbiome; in fact, the total number of microbial cells in the human body is known to vastly outnumber the indigenous cellular population. Of late, many studi ... Read More
-
Rare Kidney Disorders Market, 2022-2035
Rare Kidney Disorders Market, 2022-2035 The term rare kidney diseases represents around 150 different indications. It is worth highlighting that the prevalence rate of rare kidney disorders (RKD) is estimated to be 60-80 per 100,000 cases / individuals in the US and Europe. Despite their relatively ... Read More
-
Organ-on-chip Market, 2022-2035: Focus on Products and Technologies
Organ-on-chip Market, 2022-2035: Focus on Products and Technologies It is a well-known fact that almost 90% of the therapeutic interventions fail in clinical trials, resulting in significant economic losses to the pharmaceutical industry. The lack of effective preclinical prediction of drug respons ... Read More
-
Adeno-Associated Viral (AAV) Vector Market: Focus on Drugs, Manufacturers and Technologies, 2022-2035
Adeno-Associated Viral (AAV) Vector Market: Focus on Drugs, Manufacturers and Technologies, 2022-2035 Given the potential of gene therapies in targeting the underlying cause of a disease at cellular level, the demand for such therapies has increased considerably over the past few years. Currently, ... Read More
-
NAMPT Inhibitors Market, 2022-2040
NAMPT Inhibitors Market, 2022-2040 Globally, cancer is one of the leading causes of death; in 2020, about 10 million cancer related deaths were reported. Further, according to a study published in American Cancer Society Journal, by 2040, the number of cancer cases is projected to reach over 28 mil ... Read More
-
CRISPR Technologies: Intellectual Property Landscape
CRISPR Technologies: Intellectual Property Landscape Over the last two decades, genome editing concepts and genetic engineering have evolved significantly, with the development of a variety of versatile DNA modulation technologies, including clustered, regularly interspaced short palindromic repeats ... Read More
-
Tissue Engineering-based Regeneration Products Market, 2022-2035
Tissue Engineering-based Regeneration Products Market, 2022-2035 Research indicates that about 6% of the individuals are expected to get affected from chronic wounds, globally. Specifically, in the US, 6.5 million individuals are estimated to be affected by chronic wounds. Financially, treatment of ... Read More
-
Mini Bioreactors and Micro Bioreactors Market, 2022-2035
Mini Bioreactors and Micro Bioreactors Market, 2022-2035 With several blockbuster therapies (such as Humira®, Rituxan®, Lantus®, Avastin®, Herceptin® and Remicade®) and a robust pipeline of product / therapy candidates, the biopharmaceutical market is anticipated to witness significant growth in the ... Read More
Research Assistance
